Because LY-411575 inhibits not only γ-secretase and Notch signalling but also SPP, it is unclear which inhibitory effects of LY-411575 participate in the improvement of CoreTg-induced insulin resistance and steatosis. This evidence concerns the gene HM13 and steatosis.